“Headquarters Involvement Clear” in Access to Patient Medical Charts by Bayer Sales Reps: Attorney for Whistleblower

April 20, 2017
Tomohiro Kurohara, Attorney for Whistleblower Bayer Yakuhin and the health ministry should investigate the entire issue of the survey scandal surrounding Bayer Yakuhin’s anticoagulant Xarelto (rivaroxaban), an attorney representing the company’s sales rep who reported the scandal said on April...read more